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During last years, evidence has been provided on the involvement of obesity in the pathogenesis 
and aggravation of several life-threatening diseases. In this view, we set up an innovative protocol 
to induce a nanoparticle-mediated lipolysis in vitro by combining light and electron microscopy, 
and biochemical approaches. Under appropriate administration conditions, 3T3-L1 mouse 
adipocytes proved to efficiently and safely internalize superparamagnetic iron oxide nanoparticles 
(SPIONs), which are able to produce heat when subjected to alternating magnetic field (1-3). Thus, 
3T3-L1 adipocytes were submitted to SPIONs-mediated hyperthermia treatment (SMHT), with the 
aim of modulating their lipid content (4,5). The treatment resulted in a significant delipidation 
persisting for at least 24 h, in the absence of cell death, damage or dedifferentiation. Interestingly, 
some factors normally linked with lipolysis event or in lipid metabolism (6) were not modulated 
upon SMHT, suggesting the involvement of a novel/alternative mechanism in the lipolysis 
observed. Notably, the same SMHT was able to induce delipidation also in primary cultures of 
human adipose-derived adult stem cells. The success of this new approach in vitro opens promising 
perspectives for the application of SMHT in different biomedical fields. Next steps could be the use 
of SPIONs in an animal model of obesity, to analyze the metabolic pathways activated by the 
SMHT, and the application of SMHT in an experimental model of cancer in obese mice to study the 
crosstalk between adipose and tumor tissues. 
 
References 
1. Lee JH et al. Nat Nanotechnol 2011, 6:418-22. 
2. Guardi P et al. ACS Nano 2012, 6:3080-91. 
3. Orlando T et al. Contrast Media Mol Imaging 2016, 11:139-45. 
4. Bernabucci U et al. J Mol Endocrinol 2009, 42:139-47. 
5. Sharifi S et al. Sci Rep 2013, 3:2173. 
6. Brasaemle DL. J Lipid Res 2007, 48:2547-59. 
 
 
